TSX: AKL       Akela Pharma Inc
Last Price Today's Change   Day's Range   Trading Volume
0.00   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
Average Price Target:-


No recent Headlines for this stock.

Business Background

Akela Pharma, Inc. (Akela) is a drug development company. The Company is a pharmaceutical formulation developer as well as clinical and commercial drug manufacturer for drug products through its PharmaForm subsidiary. PharmaForm engaged in the area of pharmaceutical dosage form development, controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying, fluid bed processing, and liquid filled capsules. The Company has a pipeline also includes a growth hormone releasing hormone (GHRH), which is being developed for frailty and wasting in chronic renal disease. PharmaForm, is the Company's wholly owned subsidiary which is engaged in Formulation and process development/optimization, Handling of potent compounds, Analytical testing, Clinical labeling and packaging and Patent litigation support. On August 9, 2011, the Company discontinued the Fentanyl TAIFUN program. PharmaForm, is the Company's wholly owned subsidiary.

  Be the first to like this.


721  922  1225  1685 

Top 10 Active Counters
 ACB 3.00-0.59 
 ECA 5.50-0.26 
 APHA 5.03-0.62 
 PXI 0.065+0.005 
 TGOD 0.65-0.05 
 OGC 2.66+0.06 
 WEED 18.78-1.51 
 CPG 5.21-0.08 
 BTO 4.77+0.14 
 PEY 2.86-0.18 
Partners & Brokers